文献速递帕金森病与运动障碍

帕金森病丘脑底核刺激患者的轴向症状可预测死亡风险

Axial symptoms predict mortality in patients with Parkinson disease and subthalamic stimulation.
PubMed 文献 · Neurology · 2019-05-01

该研究对143例接受丘脑底核深部电刺激(STN-DBS)的帕金森病(PD)患者进行长期随访,评估运动与认知障碍进展及死亡原因。中位观察12年,发现轴向症状进行性加重且药物与DBS疗效随时间衰减,当前轴向残疾水平是唯一显著预测死亡的指标(风险比4.30)。

要点

  • STN-DBS术后轴向症状进行性加重,药物与DBS对其疗效预计20年后无效。
  • 当前轴向残疾水平显著预测死亡风险(风险比4.30)。
  • 认知状态显著下降,但未显示独立预测死亡。

核心结论

  • 轴向残疾可显著预测PD患者STN-DBS术后的个体死亡风险,有助于制定治疗策略。

研究设计与样本

  • 研究为前瞻性队列,纳入143例连续接受STN-DBS的PD患者,术前及术后1、2、5、10年评估运动与认知功能,记录死亡原因,采用线性混合模型和联合模型分析。

主要发现

  • 中位观察时间为术后12年,期间运动不能、强直和轴向症状加重,术后1至10年(药物“开”/STN-DBS“开”状态)平均增加分别为8.8(SD 6.5)、1.8(3.1)和5.4(4.1)分。
  • 对多巴胺能药物和STN-DBS的反应随时间衰减,但除轴向症状外仍保持有效;轴向症状的两种治疗及其组合预计术后20年无效。
  • 认知状态显著下降。
  • 当前轴向残疾水平是唯一显著预测死亡的 symptoms(风险比4.30 [SE 1.50],每单位平方根转换轴向评分)。

临床怎么用

  • 临床中应密切监测STN-DBS术后PD患者的轴向症状进展,将其作为死亡风险分层和个体化治疗策略制定的依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize how disease progression is associated with mortality in a large cohort of patients with Parkinson disease (PD) with long-term follow-up after subthalamic nucleus deep brain stimulation (STN-DBS). METHODS: Motor and cognitive disabilities were assessed before and 1, 2, 5, and 10 years after STN-DBS in 143 consecutive patients with PD. We measured motor symptoms "off" and "on" levodopa and STN-DBS and recorded causes of death. We used linear mixed models to characterize symptom progression, including interactions between treatment conditions and time to determine how treatments changed efficacy. We used joint models to link symptom progression to mortality. RESULTS: Median observation time was 12 years after surgery, during which akinesia, rigidity, and axial symptoms worsened, with mean increases of 8.8 (SD 6.5), 1.8 (3.1), and 5.4 (4.1) points from year 1-10 after surgery ("on" dopamine/"on" STN-DBS), respectively. Responses to dopaminergic medication and STN-DBS were attenuated with time, but remained effective for all except axial symptoms, for which both treatments and their combination were predicted to be ineffective 20 years after surgery. Cognitive status significantly declined. Forty-one patients died, with a median time to death of 9 years after surgery. The current level of axial disability was the only symptom that significantly predicted death (hazard ratio 4.30 [SE 1.50] per unit of square-root transformed axial score). CONCLUSIONS: We quantified long-term symptom progression and attenuation of dopaminergic medication and STN-DBS treatment efficacy in patients with PD and linked symptom progression to mortality. Axial disability significantly predicts individual risk of death after surgery, which may be useful for planning therapeutic strategies in PD.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Lau B, Meier N, Serra G, et al. Axial symptoms predict mortality in patients with Parkinson disease and subthalamic stimulation. Neurology. 2019. PMID: 31043471. doi:10.1212/WNL.0000000000007562

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。